Navigation Links
OncoGenex to Present at Credit Suisse Healthcare Investor Conference
Date:11/5/2013

BOTHELL, Wash. and VANCOUVER, British Columbia, Nov. 5, 2013 /PRNewswire/ -- OncoGenex Pharmaceuticals, Inc. (NASDAQ: OGXI) announced today that Scott Cormack, President and Chief Executive Officer, will provide a corporate presentation at the Credit Suisse Healthcare Conference on Tuesday, November 12, 2013 at 8:30 a.m. MST at the Phoenician Hotel in Scottsdale, Arizona.

A live audio webcast can be accessed through the Investor Relations page of the OncoGenex website at www.oncogenex.com. The webcast replay will be archived for 60 days.

Highlights from the presentation can be followed on the new OncoGenex Investor Relations Twitter account at: http://twitter.com/@OncoGenex_IR.

ABOUT ONCOGENEX
OncoGenex is a biopharmaceutical company committed to the development and commercialization of new therapies that address treatment resistance in cancer patients. OncoGenex has a diverse oncology pipeline, with each product candidate having a distinct mechanism of action and representing a unique opportunity for cancer drug development. OncoGenex and Teva Pharmaceutical Industries Ltd. have entered a global collaboration and license agreement to develop and commercialize OncoGenex' lead drug candidate, custirsen. Custirsen is currently in Phase 3 clinical development as a treatment in men with metastatic castrate-resistant prostate cancer and in patients with advanced, unresectable non-small cell lung cancer. Apatorsen is in Phase 2 clinical development and OGX-225 is currently in pre-clinical development. More information is available at www.OncoGenex.com.


'/>"/>
SOURCE OncoGenex Pharmaceuticals, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related biology technology :

1. OncoGenex Pharmaceuticals, Inc. Provides Clinical Development Update and Reports Financial Results for Third Quarter 2012
2. OncoGenex Announces Completion Of Patient Enrollment In Custirsen Phase 3 "SYNERGY" Study
3. MGB Biopharma to Present at Bio-Europe 2013
4. First Annual Michael SanInocencio Lennox-Gastaut Syndrome Research Award Presented at Annual Meeting of the Child Neurology Society
5. RSC New England Clinicians to Present at RESOLVE New England’s 20th Annual Conference on November 2nd, 2013
6. MiMedx To Present At Canaccord Genuity Medical Technology And Diagnostics Forum
7. Successful Pediatric Studies: Key Study Design and Operational Considerations, a New Webinar Presented by Premier Research and Xtalks
8. ClearPath Workforce Management Expert to Present on Contractor Payroll, Engagement and Compliance as Part of Institute for Human Resources Virtual Conference
9. Z Trim to Present at the 2013 Clean Label Conference
10. Vet-Stem, Inc. Founder and CEO Presents at TargetMeeting’s 3rd World Drug Discovery Online Conference
11. Rancho BioSciences will present the tranSMART open source platform at TM Forum’s Digital Disruption 2013, Oct 28-31, San Jose
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/10/2019)... , ... October 10, 2019 , ... ... the largest network of clinical research centers in Europe. All Pratia research centers ... in Europe to become trained and certified as Virtual Trial Capable and prepared ...
(Date:10/3/2019)... ... October 01, 2019 , ... ... reset itself, announced the midway point of its randomized research trial for individuals ... is to measure the efficacy of a non-invasive technology which compares tones delivered ...
(Date:10/3/2019)... ... , ... eKare’s inSight® digital 3D imaging and wound measurement system has been ... Academic Health Science Network (EMAHSN), the innovation arm of the NHS. The program was ... develop and deploy solutions to the most pressing challenges facing the NHS. , ...
(Date:9/24/2019)... ... September 24, 2019 , ... ... in the area of high-level X-ray methods using synchrotron-produced X-rays to study ... Improved Pharma, will present “Synchrotron X-Ray Diffraction and Pair Distribution Function Analysis ...
Breaking Biology Technology:
(Date:10/3/2019)... ... October 01, 2019 , ... The ... chemicals, reagents, and medias and to be a more environmentally sustainable evolution to ... of years of experience and feedback from the original version we launched in ...
(Date:10/3/2019)... Conn. (PRWEB) , ... October 02, 2019 , ... ... the leading source of financing and ongoing support for Connecticut’s innovative, growing companies, ... Israel-based fraud protection company for mobile payments and winner of the 2018 ...
(Date:9/30/2019)... ... September 30, 2019 , ... USDM Life ... of life science organizations to accelerate innovation and maximize productivity, announces that David ... , What: Just 30 days to 21 CFR Part 11 compliance with Box, ...
Breaking Biology News(10 mins):